Summary of Key Information:
Reporting Period (Quarter/Year): Quarter ended June 30, 2026 (Q1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting - Financial Results and Management Changes
Date of Board Meeting / Approval: July 30, 2026
Audit Opinion: Clean (Unaudited with Limited Review)
Auditor's Comment: No material misstatements found; prepared in accordance with Ind AS 34
Key Financial Highlights [Rs. in Million]
Standalone Results:
Revenue from Operations: ₹4,105.47 (22.6% increase from ₹3,347.48 in Q1 FY26)
Total Income: ₹4,233.04
Net Profit: ₹527.06 (1.9% increase from ₹517.20 in Q1 FY26)
EPS: ₹5.20 (Basic and Diluted)
Other Equity: Not specified for current quarter
Financial Performance Comparison:
- Profit before tax: ₹705.41 (vs ₹688.20 in Q1 FY26)
- Tax expense: ₹178.35
- Total comprehensive income: ₹525.41
- Paid-up equity share capital: ₹1,015.66 million
Consolidated Results:
The consolidated financial results include the Holding Company and its subsidiaries. The unaudited interim financial results of 4 subsidiaries and 1 other consolidating entity reflect:
- Total revenues: ₹0.02 million
- Total net profit after tax: ₹1.16 million
- Total comprehensive income: ₹1.16 million
Segment-wise Performance:
The Company operates in a single business segment: rendering medical and healthcare services. All operations are concentrated in India.
Corporate Actions:
Final dividend for FY 2025-26 of ₹3.50 per equity share (aggregating ₹355.48 million) was approved by shareholders at the 28th AGM held on July 29, 2026, and paid on July 29, 2026.
Management Changes:
The Board approved the elevation of Mr. Anshuman Jaiswal from Group Head – Legal to Chief Legal Officer and designated him as Senior Management Personnel (SMP) with immediate effect from July 30, 2026.
Other Significant Information:
Subsequent to quarter end, the company executed:
1. Definitive transaction documents for development of new children and women's hospital at Malad, Mumbai through wholly owned subsidiary RWCHPL (expected completion Q2 FY27)
2. Partnership Interest and Contribution Transfer Agreement for acquisition of 64% partnership interest in Super Prime Medical Care LLP for ₹198 million (running children's hospital at Nellore, Andhra Pradesh, expected completion Q2 FY27)